Mind Medicine (MindMed) (OTCMKTS:MMEDF) Stock Price Up 10.9% – Still a Buy?

Shares of Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF) were up 10.9% on Wednesday . The stock traded as high as $8.27 and last traded at $8.17. Approximately 3,458,726 shares were traded during mid-day trading, an increase of 2% from the average daily volume of 3,376,665 shares. The stock had previously closed at $7.37.

Mind Medicine (MindMed) Price Performance

The company has a fifty day simple moving average of $7.25 and a two-hundred day simple moving average of $6.90.

About Mind Medicine (MindMed)

Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.